17 days until retatrutide phase 3 data and here's some published and unpublished data on decreases in glucose, insulin resistance and fasting insulin levels in diabetics and non-diabetics. This just in obese patients and the decrease in fasting insulin is *enormous* over 50% and still dropping!
